Wallis RM - Search Results

1

Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: current recommendations from the Safety Pharmacology Society.

Leishman DJ, Beck TW, Dybdal N, Gallacher DJ, Guth BD, Holbrook M, Roche B, Wallis RM. Leishman DJ, et al. Among authors: wallis rm. J Pharmacol Toxicol Methods. 2012 May-Jun;65(3):93-101. doi: 10.1016/j.vascn.2011.08.006. Epub 2011 Aug 31. J Pharmacol Toxicol Methods. 2012. PMID: 21907296

2

Integrated risk assessment and predictive value to humans of non-clinical repolarization assays.

Wallis RM. Wallis RM. Br J Pharmacol. 2010 Jan;159(1):115-21. doi: 10.1111/j.1476-5381.2009.00395.x. Epub 2009 Sep 25. Br J Pharmacol. 2010. PMID: 19785646 Free PMC article. Review.

3

The effect of sildenafil on corpus cavernosal smooth muscle relaxation and cyclic GMP formation in the diabetic rabbit.

Thompson CS, Mumtaz FH, Khan MA, Wallis RM, Mikhailidis DP, Morgan RJ, Angelini GD, Jeremy JY. Thompson CS, et al. Among authors: wallis rm. Eur J Pharmacol. 2001 Aug 3;425(1):57-64. doi: 10.1016/s0014-2999(01)01077-9. Eur J Pharmacol. 2001. PMID: 11672575

4

The pharmacology of sildenafil, a novel and selective inhibitor of phosphodiesterase (PDE) type 5.

Wallis RM. Wallis RM. Nihon Yakurigaku Zasshi. 1999 Oct;114 Suppl 1:22P-26P. doi: 10.1254/fpj.114.supplement_22. Nihon Yakurigaku Zasshi. 1999. PMID: 10629850 Review.

5

Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carneae and aortic rings in vitro.

Wallis RM, Corbin JD, Francis SH, Ellis P. Wallis RM, et al. Am J Cardiol. 1999 Mar 4;83(5A):3C-12C. doi: 10.1016/s0002-9149(99)00042-9. Am J Cardiol. 1999. PMID: 10078537

6

Muscarinic antagonists in development for disorders of smooth muscle function.

Wallis RM, Napier CM. Wallis RM, et al. Life Sci. 1999;64(6-7):395-401. doi: 10.1016/s0024-3205(98)00585-2. Life Sci. 1999. PMID: 10069502 Review.

7

Characterisation of [3H]-darifenacin as a novel radioligand for the study of muscarinic M3 receptors.

Smith CM, Wallis RM. Smith CM, et al. Among authors: wallis rm. J Recept Signal Transduct Res. 1997 Jan-May;17(1-3):177-84. doi: 10.3109/10799899709036602. J Recept Signal Transduct Res. 1997. PMID: 9029489

8

Characterization of muscarinic receptors mediating contractions of circular and longitudinal muscle of human isolated colon.

Kerr PM, Hillier K, Wallis RM, Garland CJ. Kerr PM, et al. Among authors: wallis rm. Br J Pharmacol. 1995 Aug;115(8):1518-24. doi: 10.1111/j.1476-5381.1995.tb16645.x. Br J Pharmacol. 1995. PMID: 8564213 Free PMC article.

9

Pre-clinical and clinical pharmacology of selective muscarinic M3 receptor antagonists.

Wallis RM. Wallis RM. Life Sci. 1995;56(11-12):861-8. doi: 10.1016/0024-3205(94)00021-j. Life Sci. 1995. PMID: 10188786 Clinical Trial.

10

Lead poisoning: clinical, biochemical, and haematological aspects of a recent outbreak.

Pagliuca A, Mufti GJ, Baldwin D, Lestas AN, Wallis RM, Bellingham AJ. Pagliuca A, et al. Among authors: wallis rm. J Clin Pathol. 1990 Apr;43(4):277-81. doi: 10.1136/jcp.43.4.277. J Clin Pathol. 1990. PMID: 2341563 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters